← Back to all signals
RESEARCH PAPER ANALYSIS

A Bias-Aware Analytic Framework for Real-World Data with AI-Audited Workflows: Application to Opioid Ordering in Pediatric Oncology.

AI interpretation is pending for this paper.

Open original publication →
PMID42938953
JournalBioengineering (Basel, Switzerland)
Publication Date2026-09-23
Ingested2026-10-28 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Background: The growing use of computational modeling of real-world data (RWD) in clinical research introduces significant risks for data scientists and AI trainers already managing inconsistency, unexamined bias, and analytical opacity. Building upon more than 600 guideline-based checklists and pre-planning templates for data quality and transparency reporting in observational RWD, we propose a run-time operational execution loop to embed reproducibility analytics within the workflow. Our approach acts as a run-time gatekeeper mapping prespecified analytics goals to a closed-loop LLM semantic code auditor, checking for both logic, bias, and vulnerabilities during code execution. Our framework was designed to bridge the gap between passive disclosure, ensuring proposed requirements, and post-hoc validation. Our structured hierarchical approach coupled with AI auditing is the first phase in the development of full-stack automation of bias-aware RWD analytic validation. Methods: Our analytic framework spans 10 domains across three analytic phases. Each domain includes prespecified criteria governing verification with potential biases, mechanisms, and mitigation strategies systematically mapped throughout. Phase I entails specification (Domains 1-4: objectives and estimands, data inputs and outputs, cohort and filters, and variable coding); Phase II: modeling (Domains 5-7: model testing, diagnostics, and reasonableness checks); and Phase III: robustness and interpretation (Domains 8-10: missing data handling, temporal and stratified checks, and scope boundaries). We utilize specific prompt-directed large language model (LLM) auditing of model elements to ensure data quality. The methodology is illustrated with examples from an empirical characterization of inpatient opioid data from the Cerner Real-World Data (2014-2021). GLMMs and corresponding outputs were generated in R v4.4.2. Curated AI-auditing of first-pass code drafting was performed using ChatGPT 5.2 (OpenAI), with cross-LLM portability assessed using Claude Sonnet 5 (Anthropic). Results: The Cerner RWD database contained 16,734 pediatric cancer patients (76,395 encounters) across 55 U.S. health systems. During the specification phase, total daily dose could not be estimated with sufficient validity from the Cerner RWD, and "as-needed" (PRN) orders, warranted empirically supported exclusion. The modeling phase revealed residual variability in opioid ordering attributable primarily to patient-level differences within health systems (ICC = 19.9%) rather than between health systems (ICC = 2.0%). Temporal analysis revealed divergent opioid-ordering trajectories from 2017 onward, with decreasing morphine and increasing fentanyl ordering. We then utilized curated prompting to enforce an AI-generated coding requirement to produce valid likelihood ratio tests across the prespecified model sequence accounting for temporal trends. After harmonizing the model specification and estimation settings, both LLM workflows produced identical random-effect variance estimates, ICCs, and AIC values evaluated through the third decimal place, with corresponding fixed-effect estimates likewise matching. Conclusions: The 10-domain framework provides a structured, reproducible mechanism for governing RWD analyses by using a closed-loop semantic code auditor to embed run-time analytics directly into the data science workflow, supporting transparent exposure definition, systematic bias assessment, and prespecified analytic decision-making. By bridging the gap between passive transparency checklists and active automation, the framework operationalizes existing data quality guidelines through an executable, bias-aware code-auditing process. Cross-LLM concordance in identifying problematic logic and reproducing complex workflows supports the portability of this run-time gatekeeper. Ultimately, this approach establishes a scalable pathway for embedding expert statistical decision-making into the automation of safe, reliable real-world evidence (RWE) generation.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Pharmacological thromboprophylaxis following ventriculoperitoneal shunt insertion: a single-centre experience of thromboembolic and bleeding outcomes. Acta neurochirurgica 66.5 2 Design principles of prosthetic reconstruction after pelvic tumor resection: a systematic review and perspective from modular systems to 3D-printed personalized solutions. Journal of orthopaedic surgery and research 73.9 3 Ultrasound-guided versus conventional sinus tract laser closure for adolescent sacrococcygeal pilonidal disease: a retrospective comparative study. Techniques in coloproctology 68.4 4 Biallelic MCM10 Deficiency Presenting with Natural Killer Cell Deficiency, Poikiloderma and EBV-Associated Malignancy. Journal of clinical immunology 56.0 5 A qualitative exploration of the psychosocial burden and coping among adolescents and young adults with hematologic malignancies. BMC cancer 64.1 6 Preliminary Psychometric Evaluation of an Ultraviolet Radiation-Related Questionnaire in a Case-Control Sample. Ocular oncology and pathology 70.4 7 Forty Years Later-Complications and Mortality Associated with Cultured Epithelial Autografts in Burn Patients: A Systematic Review. Bioengineering (Basel, Switzerland) 78.1 8 Early Cardiotoxicity in Pediatric Patients with Acute Lymphoblastic Leukemia and Hodgkin Lymphoma: Incidence, Risk Factors, and Clinical Implications. Children (Basel, Switzerland) 74.62 9 Evaluating the Role of Anti-PEG Antibodies in Hypersensitivity to PEG-Asparaginase Through Clinically Relevant Cut-Points Defined by ELISA and Surface Plasmon Resonance. Pharmaceutics 62.0 10 Pediatric Microbiota: Evidence and Future Perspectives-A Conference Report. Microorganisms 65.0 11 All-Trans Retinoic Acid Nanocrystals for Enhanced Anticancer Activity Against Neuroblastoma Cancer Stem Cells. Pharmaceutics 53.3 12 Contribution of MTHFR C677T and A1298C Variants to Retinoblastoma Risk in Mexican Children. Genes 64.5 13 EBUS-Guided Cryobiopsy in a Pediatric Inflammatory Mediastinal Tumor With ROS1 Fusion: A Case Report. Pediatric pulmonology 39.0 14 Epidemiology of Kaposi's Sarcoma in Uzbekistan, 2016-2024: Gender-, Age-, and Region-Specific Differences. Asian Pacific journal of cancer prevention : APJCP 37.0 15 Design and Validation of Evidence-Based Peripheral Chemotherapy-Induced Neuropathy Guideline Among the Children with Cancer. Asian Pacific journal of cancer prevention : APJCP 75.34 16 Institutional and Demographic Barriers to Cervical Cancer Screening among Women in Rivers State, Nigeria. Asian Pacific journal of cancer prevention : APJCP 59.5 17 Endoscopic endonasal management of giant pediatric craniopharyngioma. Neurosurgical focus: Video 54.0 18 Keyhole endoscopic resection of pediatric craniopharyngioma via a precoronal transventricular transforaminal approach: "small door, big win.": Two-dimensional operative video. Neurosurgical focus: Video 54.0 19 Subpial dissection technique in endoscopic endonasal surgery for craniopharyngiomas with supradiaphragmatic extension. Neurosurgical focus: Video 35.0 20 Modern craniopharyngioma management: three illustrative cases with distinct therapeutic strategies. Neurosurgical focus: Video 62.04 21 Management of a giant pediatric craniopharyngioma: staged endoscopic endonasal and cranial approaches. Neurosurgical focus: Video 54.0 22 Excision of pediatric craniopharyngioma with complicated features: the value of additional "tailored" cavernous sinus exposure in the standard pterional approach. Neurosurgical focus: Video 56.4 23 Incidental Mandibular Intraosseous Findings in Neurofibromatosis Type 1: CBCT and MRI Features Influencing Clinical Management. Nigerian journal of clinical practice 60.8 24 Mitochondria as Key Players in Sarcoma Development, Progression and Drug Resistance: From Mechanistic Insights to New Treatment Opportunities. Biomolecules 70.6 25 Anodal Transcranial Direct Current Stimulation Reduces Neuroinflammation and Cholinergic Dysregulation After Young Adult Traumatic Brain Injury. Biomolecules 41.7 26 The Antigen-Presentation Bottleneck in Pediatric Solid Tumors: Developmental Antigens, MHC-I Suppression, and Therapeutic Restoration of Tumor Immune Recognition. Biomolecules 66.44 27 Factors Associated with Ventriculoperitoneal Shunt Placement Following Posterior Fossa Tumor Resection in Children: A Systematic Review and Meta-Analysis. Medicina (Kaunas, Lithuania) 75.0 28 Clinical outcomes and prognostic factors in pediatric acute myeloid leukemia with monocytic differentiation: a single-center cohort study from Egypt. Frontiers in oncology 77.8 29 Multi-cohort screening of PANoptosis-related genes reveals PARP1 as a key target, and AZD5305 exerts anti-tumor effects in neuroblastoma. Frontiers in oncology 62.2 30 Extensive vertebral compression fractures as the initial manifestation of childhood B-cell acute lymphoblastic leukemia despite limited peripheral blood abnormalities: a case report. Frontiers in pediatrics 51.4 31 Cervical cancer screening willingness and associated health beliefs among predominantly college-educated young women attending gynecology clinics in Shenzhen, China. Frontiers in public health 59.0 32 Genomic Determinants of Induction Failure and Persistent Prognostic Risk of FLT3-ITD in Pediatric Acute Myeloid Leukemia. Cancers 75.3
PATIENT-FRIENDLY SUMMARY

A Bias-Aware Analytic Framework for Real-World Data with AI-Audited Workflows: Application to Opioid Ordering in Pediatric Oncology.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic